The hardware and bandwidth for this mirror is donated by METANET, the Webhosting and Full Service-Cloud Provider.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]metanet.ch.
The field of immunology benefits from software that can predict which peptide sequences trigger an immune response. 'NetMHCIIpan' is a such a tool: it predicts the binding strength of a short peptide to a Major Histocompatibility Complex class II (MHC-II) molecule. 'NetMHCIIpan' can be used from a web server at <https://services.healthtech.dtu.dk/services/NetMHCIIpan-3.2/> or from the command-line, using a local installation. This package allows to call 'NetMHCIIpan' from R.
Version: | 1.3.2 |
Imports: | devtools, dplyr, rappdirs, readr, seqinr, stringr, testit, tibble |
Suggests: | knitr, rmarkdown, testthat, spelling |
Published: | 2023-11-08 |
DOI: | 10.32614/CRAN.package.netmhc2pan |
Author: | Richèl J.C. Bilderbeek [aut, cre], Lue Ping Zhao [ctb], Byungkuk Min [ctb] |
Maintainer: | Richèl J.C. Bilderbeek <richel at richelbilderbeek.nl> |
BugReports: | https://github.com/richelbilderbeek/netmhc2pan/issues |
License: | GPL-3 |
URL: | https://github.com/richelbilderbeek/netmhc2pan/ |
NeedsCompilation: | no |
SystemRequirements: | NetMHC2pan (https://services.healthtech.dtu.dk/service.php?NetMHCIIpan-3.2) |
Language: | en-US |
CRAN checks: | netmhc2pan results |
Reference manual: | netmhc2pan.pdf |
Vignettes: |
Demo |
Package source: | netmhc2pan_1.3.2.tar.gz |
Windows binaries: | r-devel: netmhc2pan_1.3.2.zip, r-release: netmhc2pan_1.3.2.zip, r-oldrel: netmhc2pan_1.3.2.zip |
macOS binaries: | r-release (arm64): netmhc2pan_1.3.2.tgz, r-oldrel (arm64): netmhc2pan_1.3.2.tgz, r-release (x86_64): netmhc2pan_1.3.2.tgz, r-oldrel (x86_64): netmhc2pan_1.3.2.tgz |
Old sources: | netmhc2pan archive |
Please use the canonical form https://CRAN.R-project.org/package=netmhc2pan to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.